OncoMark Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 5

Employees

  • Latest Deal Type
  • M&A

OncoMark General Information

Description

Developer of a healthcare device intended to cut the number of patients receiving chemotherapy unnecessarily. The company's device detects early-stage breast cancer by measuring the expression of prognostic genes and estimates the probability of distant recurrence of cancer, enabling clinicians to determine treatment options for their patients and ultimately improving the patent's quality of life.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Parent Company
Corporate Office
  • NovaUCD, Belfield Innovation Park
  • Belfield
  • Dublin 4
  • Ireland
+353 (01) 000 0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

OncoMark Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Merger/Acquisition 01-Mar-2021 00.000 Completed Generating Revenue
5. Later Stage VC 01-Jan-2019 00.000 00.000 Completed Generating Revenue
4. Later Stage VC 01-Jan-2017 00.000 00.000 Completed Generating Revenue
3. Grant 09-Sep-2015 00.000 Completed Startup
2. Grant $3.89M Completed Startup
1. Accelerator/Incubator 01-Jan-2007 Completed Startup
To view OncoMark’s complete valuation and funding history, request access »

OncoMark Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a healthcare device intended to cut the number of patients receiving chemotherapy unnecessarily. The compan
Diagnostic Equipment
Dublin, Ireland
5 As of 2022
00.000
000000&0 00.000

000000

enderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteu
0000000000 000000000
Irvine, CA
000 As of 0000
00000
00000000

000000

equat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dol
0000000000000
Gaithersburg, MD
00 As of 0000
00000
00000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

OncoMark Competitors (6)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Agendia Venture Capital-Backed Irvine, CA 000 00000 00000000
NexImmune Formerly VC-backed Gaithersburg, MD 00 00000 00000000 00000
Provista Diagnostics Formerly PE-Backed Alpharetta, GA 00 000.00 000000&0
Nimbus Therapeutics Venture Capital-Backed Boston, MA 000 00000 00000000000 00000
OrigiMed Venture Capital-Backed Shanghai, China 0000000000 0
To view OncoMark’s complete competitors history, request access »

OncoMark Executive Team (7)

Name Title Board Seat Contact Info
William M. Gallagher Co-Founder, Chairman & Chief Scientific Officer
John Crown Chief Medical Officer
You’re viewing 2 of 7 executive team members. Get the full list »

OncoMark Board Members (5)

Name Representing Role Since
Cormac Kilty Ph.D Self Board Member 000 0000
Donal O'Shea Ph.D Self Board Member 000 0000
William M. Gallagher OncoMark Co-Founder, Chairman & Chief Scientific Officer 000 0000
You’re viewing 3 of 5 board members. Get the full list »

OncoMark Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

OncoMark Former Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Danaher Industrial Controls Group Corporation Minority 000 0000 000000 0
Enterprise Ireland Venture Capital Minority 000 0000 000000 0
European Commission Government 000 0000 000000 0
Halo Business Angel Network Angel Group Minority 000 0000 000000 0
Horizon 2020 SME Instrument Government 000 0000 000000 0
You’re viewing 5 of 8 investors. Get the full list »

OncoMark FAQs

  • When was OncoMark founded?

    OncoMark was founded in 2007.

  • Who is the founder of OncoMark?

    William M. Gallagher and Stephen Penney are the founders of OncoMark.

  • Where is OncoMark headquartered?

    OncoMark is headquartered in Dublin, Ireland.

  • What is the size of OncoMark?

    OncoMark has 5 total employees.

  • What industry is OncoMark in?

    OncoMark’s primary industry is Diagnostic Equipment.

  • Is OncoMark a private or public company?

    OncoMark is a Private company.

  • What is OncoMark’s current revenue?

    The current revenue for OncoMark is 00000.

  • How much funding has OncoMark raised over time?

    OncoMark has raised $6.99M.

  • Who are OncoMark’s investors?

    Danaher Industrial Controls Group, Enterprise Ireland, European Commission, Halo Business Angel Network, and Horizon 2020 SME Instrument are 5 of 8 investors who have invested in OncoMark.

  • Who are OncoMark’s competitors?

    Agendia, NexImmune, Provista Diagnostics, Nimbus Therapeutics, and OrigiMed are some of the 6 competitors of OncoMark.

  • When was OncoMark acquired?

    OncoMark was acquired on 01-Mar-2021.

  • Who acquired OncoMark?

    OncoMark was acquired by Cepheid.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »